Clinical trial Recruiting at 10 sites Phase 3 Interventional Ages 29 Weeks to 36 Weeks

InfasurfAero™ for treating respiratory distress in preterm newborns

Official title: InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS: A Single-dose, Double-blind, Random Allocation, Sham-control, Clinical Trial

Run by Ony · NCT05960929 · Data updated 2026-11-12

This study is testing a new device that delivers a treatment for breathing problems in preterm newborns to see if it helps them breathe better without needing a breathing tube.

More Intubation Complication trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages29 Weeks to 36 Weeks
SexAll
Enrollment220 (estimated)
SponsorOny
Industry-sponsored
Locations10 sites (Phoenix, Arizona and 9 other locations)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedJanuary 1, 2026
Study endsApril 1, 2026
Registry record updatedMarch 30, 2025
Trial IDNCT05960929 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are preterm newborns aged between 1 to 6 hours, with a gestational age of 29 to 35 weeks and diagnosed with surfactant-deficient RDS.

Probably not a fit

Patients who have received surfactant treatment or mechanical ventilation prior to randomization will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness and safety of Infasurf® delivered through the InfasurfAero™, a novel device designed for non-invasive administration without the need for intubation. The study involves a double-blind, randomized, sham-controlled design, where preterm newborns with respiratory distress syndrome (RDS) will receive either Infasurf or a sham treatment. The primary objectives are to assess the prevention of CPAP failure and the safety of the treatment. Participants will be recruited from multiple sites, with a focus on those who are stable on non-invasive respiratory support.

Why it matters

Potential benefit: If successful, this treatment could significantly improve respiratory support for preterm newborns with RDS, reducing the need for invasive procedures.

How similar studies have gone: Other studies have shown promise with similar non-invasive approaches for treating RDS, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Inclusion criteria include ALL of the following:

1. Written informed consent obtained by parent or legal representative prior to or after birth
2. Gestational age at birth ≥ 29 0/7 AND ≤ 35 6/7 weeks
3. Birthweight ≥ 1,000 AND ≤ 3,500 grams
4. Age ≥ 1 hour AND ≤ 6 hours
5. Clinical diagnosis of surfactant-deficient RDS, with EITHER i. a Silverman-Anderson Retraction Score ≥ 5 (in Room Air), OR ii. signs of respiratory distress (tachypnea, retractions, grunting) AND radiographic confirmation
6. Require CPAP
7. Respiratory Severity Score (RSS) ≥ 1.25 AND ≤ 2.4
8. If subject is \>346/7 weeks' gestation a chest radiograph is required

Exclusion Criteria:

Exclusion criteria are ANY of the following:

1. Surfactant administration prior to randomization
2. Mechanical ventilation prior to randomization
3. Major congenital anomaly (suspected or confirmed)
4. Abnormality of the airway (suspected or confirmed)
5. Respiratory distress presumed secondary to an etiology other than RDS (e.g., suspected pulmonary hypoplasia, pneumothorax, meconium aspiration syndrome, pneumonia, septic or hypovolemia shock, hypoxic ischemic encephalopathy)
6. Apgar score \< 3 at 5 minutes of age
7. Umbilical cord gas pH \<7.0 or BD \> 10
8. Any condition that, in the opinion of the Investigator, would place the neonate at undue risk

Where it's running

  • St. Josephs Hospital and Medical Center
    Phoenix, Arizona, United States
    Recruiting
  • Phoenix Children's
    Phoenix, Arizona, United States
    Recruiting
  • Sharp Mary Birch Hospital for Women & Newborns
    San Diego, California, United States
    Recruiting
  • University of Florida -Jacksonville
    Jacksonville, Florida, United States
    Recruiting
  • Kapi'olani Medical Center for Women & Children
    Honolulu, Hawaii, United States
    Recruiting
  • Jersey Shore University Medical Center
    Neptune City, New Jersey, United States
    Recruiting
Show 4 more locations
  • Sisters of Charity Hospital
    Buffalo, New York, United States
    Recruiting
  • Western TN- Jackson-Madison County General Hospital
    Jackson, Tennessee, United States
    Recruiting
  • Utah Valley Hospital
    Provo, Utah, United States
    Recruiting
  • Unity Point Meriter
    Madison, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.